Advertisement

Rifampin Induced Thrombotic Thrombocytopenic Purpura

  • Hannah Hamad
  • Kamal Kant SahuEmail author
  • Steven Dunn
  • Lucia Milla
  • Alice Caffery
  • Nahida Islam
Correspondence
  • 3 Downloads

To the Editor,

Thrombotic thrombocytopenic purpura (TTP) is one of the rare but fatal entity. The close differentials like hemolytic uremic syndrome (HUS) and atypical hemolytic uremic syndrome (atypical HUS) needs to be promptly ruled out as the management differs with the diagnosis. Rifampin induced TTP is limited to few case reports. This rare association should always be considered in any case who presents with anemia and thrombocytopenia.

A 55-year-old female presented for the complaints of malaise, headache, anorexia, and nausea of one-week duration. She denied fever, chills, cough, expectoration, abdominal pain and diarrhea. Three weeks ago, she was started on rifampin 150 mg once daily for latent tuberculosis. To note that earlier, she developed isoniazid (INH) induced hepatotoxicity following which INH was stopped and rifampin was started.

On examination, her vitals were stable and was alert and oriented to time, place and person. No pallor, jaundice, petechial spots,...

Notes

Author Contribution

All authors have seen the manuscript and agree to the content and data. All the authors played a significant role in the paper.

Funding

None.

Compliance with Ethical Standards

Conflict of interest

Authors have no conflicts of interest to declare.

Ethical Statement

The article doesn’t contain participation of any human being and animal.

References

  1. 1.
    Mirlohi MS, Ekrami A, Shirali S, Ghobeishavi M, Pourmotahari F (2016) Hematological and liver toxicity of anti-tuberculosis drugs. Electron Phys 8(9):3005–3010CrossRefGoogle Scholar
  2. 2.
    Dosi R, Chandelkar A, Jain A, Motiwale S, Joshi P, Jain P (2019) Rifampicin-induced thrombocytopenia: a rare complication. J Assoc Chest Phys 7:38–40CrossRefGoogle Scholar
  3. 3.
    Choong K, Looke D (2011) Cross-reaction to rifabutin after rifampicin induced flu-like syndrome and thrombocytopenia. Scand J Infect Dis 43(3):238CrossRefGoogle Scholar
  4. 4.
    Fahal IH, Williams PS, Clark RE, Bell GM (1992) Thrombotic thrombocytopenic purpura due to rifampicin. BMJ 304(6831):882CrossRefGoogle Scholar
  5. 5.
    Gupta R, Wargo KA (2005) Rifampin-induced thrombotic thrombocytopenic purpura. Ann Pharmacother 39(10):1761–1762CrossRefGoogle Scholar
  6. 6.
    Lal A, Mishra AK, Sahu KK, Abraham GM (2019) The return of Koch's: Ineffective treatment or re-infection. Enferm Infecc Microbiol Clin.  https://doi.org/10.1016/j.eimc.2019.06.001
  7. 7.
    Dhibar DP, Sahu KK, Dhir V, Singh S. Immune Thrombocytopenia as a Presenting Manifestation of Tuberculosis- Challenge in Resource Constraint Settings. J Clin Diagn Res. 2016 10(10): OD01-OD02.Google Scholar
  8. 8.
    Sahu KK, Varma SC (2016) Cortical vein thrombosis in a case of idiopathic thrombocytopenic purpura. Platelets 26(4):374–375CrossRefGoogle Scholar
  9. 9.
    Sahu KK, Petrou N, Cohn Z, Bathini V (2019) Splenic sequela of babesiosis.  https://doi.org/10.1093/qjmed/hcz281

Copyright information

© Indian Society of Hematology and Blood Transfusion 2020

Authors and Affiliations

  1. 1.University of Massachusetts Medical SchoolWorcesterUSA
  2. 2.Saint Vincent HospitalWorcesterUSA
  3. 3.Hemato-Oncology DivisionUniversity of Massachusetts Medical SchoolWorcesterUSA

Personalised recommendations